Licorice Coughing Liquid Recalled for Undeclared Morphine
Master Herbs is recalling Licorice Coughing Liquid because it contains undeclared morphine and was marketed without an approved NDA or ANDA.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 according to the rubric. Additionally, the presence of undeclared morphine in an OTC product represents a critical safety hazard.
Plain-English summary
Master Herbs, Inc. is recalling Licorice Coughing Liquid (guaifenesin), 5%, 3.38 fl. oz. (100 ml), OTC. The product is manufactured by Ma Ying Long Pharmaceutical Group Co., LTD in Wuhan, China, and distributed by Master Herbs (USA) Inc. The recall involves 6,024 bottles and is distributed nationwide.
The recall is being conducted because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) and contains undeclared morphine. The source text does not specify which lots are affected, though the structured metadata indicates 'all lots'.
Consumers should stop using the product and contact the recalling firm for instructions on how to return it or obtain a refund.
The recalled product
- Product
- Licorice Coughing Liquid (guaifenesin), 5%, 3.38 fl. oz. (100 ml), OTC, Manufactured by: Ma Ying Long Pharmaceutical Group Co., LTD, Wuhan, China; Distributed by: Master Herbs (USA) Inc., NDC 68511-0460-01
- Manufacturer
- Master Herbs, Inc./Li
- Category
- Drug — OTC Cough Medicine
- Affected units
- 6,024
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all lots
Distribution
Distributed nationwide across the United States.
Related recalls
Other drug recalls
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02